Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Karyopharm Therapeut

(NASDAQ: KPTI)
Add to Portfolio
-0.59 (-5.21%)
as of Sep 20, 2019

Values in US Thousands
  12-2018 12-2017 12-2016 12-2015
Sales $ 30,336 $ 1,605 $ 154 $ 250
Gross Profit 30,336 1,605 154 250
Operating Expenses 210,219 132,143 110,886 119,326
Operating Income -179,883 -130,538 -110,732 -119,076
Interest Expense 2,493 - - -
Other Income/Expenses 3,995 1,617 1,294 895
Pre-tax Income -178,381 -128,921 -109,438 -118,181
Income Taxes 26 63 139 -
Net Income from Cont. Operations -178,407 -128,984 -109,577 -118,181
Total Net Income $ -178,407 $ -128,984 $ -109,577 $ -118,181
Basic EPS from Cont. Ops. -3.14 -2.81 -2.92 -3.32
Basic EPS from Total Ops. -3.14 -2.81 -2.92 -3.32
Diluted EPS from Cont. Ops -3.14 -2.81 -2.92 -3.32
Diluted EPS from Total Operations -3.14 -2.81 -2.92 -3.32
EBITDA -177,699 -128,638 -108,816 -116,664